Manufacturing issues mar ITM's radiopharma filing, says FDA
ITM's first attempt to score FDA approval for one of its radiopharma therapies has been knocked back by the agency.
Newsletters and Deep Dive digital magazine
ITM's first attempt to score FDA approval for one of its radiopharma therapies has been knocked back by the agency.
Trump has signed an order that rips up the current US policy on childhood vaccines, demanding changes that experts say will put children at risk.
Eli Lilly's oral GLP-1 agonist Foundayo has been approved for weight management and type 2 diabetes in the UK, its first European market.
Here, we examine the early realities of JCA implementation, exploring whether the system is delivering greater alignment across European markets.
TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.
Editor's Picks
Newsletters and Deep Dive
digital magazine